Skip to main content
Premium Trial:

Request an Annual Quote

TGen to Use GE Healthcare’s IN Cell Analyzer for Cancer Research

NEW YORK (GenomeWeb News) - GE Healthcare said today that it has entered into a strategic alliance with the Translational Genomics Research Institute in which TGen will apply its IN Cell Analyzer 1000 and 3000 to cancer research.
 
"This collaboration could result in a better understanding of the biological mechanisms involved in oncology, many of which are not currently well understood by the medical community," said Spyro Mousses, director of pharmaceutical genomics and cancer drug development at TGen, in a statement.
 
TGen expects to use GE's cellular imaging systems to observe cellular morphology and perform cytometry. "Most importantly, we can more accurately collect multi-parametric information about how cells are responding to specific genetic perturbations and to specific drug exposures," Mousses said.
 
Financial terms of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.